Insider Transactions in Q2 2024 at Brainstorm Cell Therapeutics Inc. (BCLI)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2024
|
Hartoun Hartounian EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|
|
May 28
2024
|
Chaim Lebovits President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+1.27%
|
$0
$0.52 P/Share
|
|
May 22
2024
|
Chaim Lebovits President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+2.13%
|
$0
$0.64 P/Share
|
|
May 21
2024
|
Chaim Lebovits President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+2.17%
|
$0
$0.58 P/Share
|
|
May 13
2024
|
Chaim Lebovits President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+0.9%
|
$0
$0.49 P/Share
|
|
May 11
2024
|
Chaim Lebovits President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+0.91%
|
$0
$0.47 P/Share
|
|
May 10
2024
|
Chaim Lebovits President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+1.82%
|
$0
$0.46 P/Share
|
|
May 07
2024
|
Chaim Lebovits President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
66,300
+5.89%
|
$0
$0.37 P/Share
|
|
May 06
2024
|
Chaim Lebovits President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
135,000
+11.96%
|
$0
$0.38 P/Share
|
|
Apr 19
2024
|
Chaim Lebovits President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+1.72%
|
$0
$0.52 P/Share
|
|
Apr 18
2024
|
Chaim Lebovits President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
115,072
+12.0%
|
$0
$0.53 P/Share
|
|
Apr 17
2024
|
Chaim Lebovits President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
130,000
+15.14%
|
$0
$0.55 P/Share
|